Skip to main content


Fig. 1 | BMC Dermatology

Fig. 1

From: Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database

Fig. 1

Measurement of non-BT refill period and medical costs. Legends: a Measurement of non-BT refill period. 1The treatment interval per individual prescription was defined as 30 days for ADL, IFX, SCK, and 90 days for UST. It was based on the approved dosage and treatment regimen for each BT, which is shown in Appendix A. 2Medication Gap: 60 days for ADL, IFX, SCK, and UST. b Measurement of medical costs

Back to article page